Cancer clinical trials in the region Grand Est
286 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Stomach and esophageal cancer
Sarcoma and GIST
#NCT05009927
#2024-512631-77-00
Required histologic types
GIST
Required histologic sub types
Gastrointestinal stromal tumor
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
KIT
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
6 recruiting sites
Centre Léon Bérard
Phase 2
Sarcoma and GIST
#NCT03548428
#2024-511313-38-00
Required histologic types
Soft tissue sarcoma
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
1
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
5 recruiting sites
Centre Antoine Lacassagne
Phase 2
Breast cancer
#NCT06680596
#2024-515349-41-00
Required HER2 statuses
HER2 Low
Required HR statuses
HR Positive
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Excluded previous treatments at advanced or metastatic stage
Antibody Drug Conjugates (ADC)
Hormone therapy
34 recruiting sites
UNICANCER
Phase 2
Colon cancer
Rectal cancer
Stomach and esophageal cancer
#NCT06245356
#2023-508724-35-00
Required histologic types
Stomach
Oesogastric junction
Esophagus
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
4 recruiting sites
UNICANCER
Phase 2
Lung cancer
#NCT06620835
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
ALK
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Targeted therapy
4 recruiting sites
Groupe Français de Pneumo-Cancérologie
Phase 2
Sarcoma and GIST
#NCT04698785
Required histologic types
Bone sarcoma
Required disease stage
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
1
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Targeted therapy
8 recruiting sites
Centre Léon Bérard
Phase 2
Acute leukemia
#NCT05260528
#2022-500295-60-00
Required histologic types
Acute myeloid leukemia (AML)
Required number of previous lines of therapy
None
31 recruiting sites
Centre Hospitalier Universitaire de Nice
Phase 2
Head and neck cancer
#NCT05582122
Required histologic types
Oropharynx
Required histologic sub types
Squamous cell carcinoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Radiochemotherapy
Required P16 statuses
P16 Positive
10 recruiting sites
UNICANCER
Phase 2
Head and neck cancer
#NCT06640725
#2023-510559-41-00
Required histologic types
Oral cavity
Oropharynx
Hypopharynx
Larynx
Required histologic sub types
Squamous cell carcinoma
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Required CPS scores
CPS Positive (1 <= X < 20)
CPS Positive (X >= 20)
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
6 recruiting sites
Groupe Oncologie Radiothérapie Tête et Cou (GORTEC)
Phase 2
Prostate cancer
#NCT06172478
#2023-507641-29-00
Cancer de la prostate résistant à la castration
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy
Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
9 recruiting sites
Daiichi Sankyo